Data Tables

View HTML		View PDF
Section XV
15.1	Waiting Time Before Transplant - Excluding Inactive Time, Censored at WL Removal New Waiting List Registrations, 1995 to 2004	(36 k)
15.2	Time to Transplant, 1995 to 2004 New Liver Waiting List Registrations	(69 k)
	Blood Type
	Age
	Gender
	All Patient Types
	Patient Status
	Previous Transplant Any Organ
	Race
	Residency
15.3	Time to Transplant, 1995 to 2004 New Heart Waiting List Registrations	(60 k)
	Blood Type
	Age
	Gender
	All Patient Types
	Patient Status
	Previous Transplant Any Organ
	Race
	Residency
15.4a	Steroid Avoidance Rate at Discharge, 1995 to 2004 Recipients of Deceased Donor Kidneys	(38 k)
	Steroid Avoidance Rate at Discharge
	One Year Following Transplantation
	Two Years Following Transplantation
15.4b	Steroid Avoidance Rate at Discharge, 1995 to 2004 Recipients of Living Donor Kidneys	(38 k)
	Steroid Avoidance Rate at Discharge
	One Year Following Transplantation
	Two Years Following Transplantation
15.5a	Steroid Avoidance Rate at Discharge, 1995 to 2004 Recipients of Deceased Donor Livers	(38 k)
	Steroid Avoidance Rate at Discharge
	One Year Following Transplantation
	Two Years Following Transplantation
15.5b	Steroid Avoidance Rate at Discharge, 1995 to 2004 Recipients of Living Donor Livers	(37 k)
	Steroid Avoidance Rate at Discharge
	One Year Following Transplantation
	Two Years Following Transplantation
15.6	Steroid Avoidance Rate at Discharge, 1995 to 2004 Recipients of Heart Transplants	(37 k)
	Steroid Avoidance Rate at Discharge
	One Year Following Transplantation
	Two Years Following Transplantation
15.7	Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2002 Recipients with Kidney Transplants	(32 k)
15.8	Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2002 Recipients with Pancreas Transplant Alone (PTA) Transplants	(31 k)
15.9	Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2002 Recipients with Pancreas After Kidney (PAK) Transplants	(31 k)
15.10	Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2002 Recipients with Kidney-Pancreas Transplants	(31 k)
15.11	Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2002 Recipients with Liver Transplants	(32 k)
15.12	Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2002 Recipients with Intestine Transplants	(30 k)
15.13	Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2002 Recipients with Heart Transplants	(32 k)
15.14	Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2002 Recipients with Lung Transplants	(31 k)
15.15	Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2002 Recipients with Heart-Lung Transplants	(31 k)